Vaxcyte, Inc. (FRA:5VA)
Germany · Delayed Price · Currency is EUR 40.80
+0.20 (0.49%)
At close: Nov 28, 2025
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of €5.13 billion as of December 2, 2025. Its market cap has decreased by -56.09% in one year.
Market Cap
5.13B
Enterprise Value
3.73B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€40.80
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from 1.22B to 5.13B, an increase of 318.53%. That is a compound annual growth rate of 29.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 5.60B | -43.17% |
| Dec 31, 2024 | 9.85B | 82.29% |
| Dec 29, 2023 | 5.41B | 52.56% |
| Dec 30, 2022 | 3.54B | 220.92% |
| Dec 31, 2021 | 1.10B | -0.22% |
| Dec 31, 2020 | 1.11B | -9.64% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |